The DOI matches its Crossref record; 76 of the 76 references it cites were found in a registry or an index.
Taxol-Induced Mitotic Block Triggers Rapid Onset of a p53-Independent Apoptotic Pathway
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Apoptosis: A Basic Biological Phenomenon with Wideranging Implications in Tissue Kinetics
Kerr, J. F. R., Wyllie, A. H., & Currie, A. R. (1972) · British Journal of Cancer · doi:10.1038/bjc.1972.33 · Cited by 15,725
A genetic model for colorectal tumorigenesis
Fearon, E. R., & Vogelstein, B. (1990) · Cell · doi:10.1016/0092-8674(90)90186-i · Cited by 12,132
Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation.
Gavrieli, Y., Sherman, Y., & Ben-Sasson, S. A. (1992) · The Journal of cell biology · doi:10.1083/jcb.119.3.493 · Cited by 9,444
WAF1, a potential mediator of p53 tumor suppression
El-Deiry, W. S., Tokino, T., Velculescu, V. E., Levy, D. B., Parsons, R., Trent, J. M., Lin, D., Mercer, W. E., Kinzler, K. W., & Vogelstein, B. (1993) · Cell · doi:10.1016/0092-8674(93)90500-p · Cited by 8,321
p53 Mutations in Human Cancers
Hollstein, M., Sidransky, D., Vogelstein, B., & Harris, C. C. (1991) · Science · doi:10.1126/science.1905840 · Cited by 8,018
The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases.
Wade Harper, J. (1993) · Cell · doi:10.1016/0092-8674(93)90499-g · Cited by 5,651
Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours
Donehower, L. A., Harvey, M., Slagle, B. L., McArthur, M. J., Montgomery, C. A., Butel, J. S., & Bradley, A. (1992) · Nature · doi:10.1038/356215a0 · Cited by 4,649
The p53 tumour suppressor gene
Levine, A. J., Momand, J., & Finlay, C. A. (1991) · Nature · doi:10.1038/351453a0 · Cited by 3,788
Participation of p53 protein in the cellular response to DNA damage.
Kastan, M. B., Onyekwere, O. C., Sidransky, D., Vogelstein, B., & Craig, R. W. (1991) · PubMed · Cited by 3,761
p21 is a universal inhibitor of cyclin kinases
Xiong, Y., Hannon, G. J., Zhang, H., Casso, D., Kobayashi, R., & Beach, D. (1993) · Nature · doi:10.1038/366701a0 · Cited by 3,368
p53-dependent apoptosis modulates the cytotoxicity of anticancer agents
Lowe, S. W., Ruley, H. E., Jacks, T., & Housman, D. E. (1993) · Cell · doi:10.1016/0092-8674(93)90719-7 · Cited by 2,925
p53 is required for radiation-induced apoptosis in mouse thymocytes
Lowe, S. W., Schmitt, E. M., Smith, S. W., Osborne, B. A., & Jacks, T. (1993) · Nature · doi:10.1038/362847a0 · Cited by 2,864
Thymocyte apoptosis induced by p53-dependent and independent pathways
Clarke, A. R., Purdie, C. A., Harrison, D. J., Morris, R. G., Bird, C. C., Hooper, M. L., & Wyllie, A. H. (1993) · Nature · doi:10.1038/362849a0 · Cited by 2,271
WAF1/CIP1 is induced in p53-mediated G1 arrest and apoptosis.
El‐Deiry, W. S., Harper, J. W., O'Connor, P. M., Velculescu, V. E., Ce, C., Jackman, J., Pietenpol, J. A., Burrell, M., De, H., & Wang, Y. (1994) · PubMed · Cited by 2,078
Taxol stabilizes microtubules in mouse fibroblast cells.
Schiff, P. B., & Horwitz, S. B. (1980) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.77.3.1561 · Cited by 1,970
Dulić, V., Kaufmann, W. K., Wilson, S. J., Tisty, T. D., Lees, E., Harper, J. W., Elledge, S. J., & Reed, S. I. (1994) · Cell · doi:10.1016/0092-8674(94)90379-4 · Cited by 1,465
McGuire, W. P., Rowinsky, E. K., Rosenshein, N. B., Grumbine, F. C., Ettinger, D. S., Armstrong, D. K., & Donehower, R. C. (1989) · Annals of Internal Medicine · doi:10.7326/0003-4819-111-4-273 · Cited by 1,100
Mechanism of mitotic block and inhibition of cell proliferation by taxol at low concentrations.
Jordan, M. A., Toso, R. J., Thrower, D., & Wilson, L. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.20.9552 · Cited by 1,095
Yin, Y., Tainsky, M. A., Bischoff, F. Z., Strong, L. C., & Wahl, G. M. (1992) · Cell · doi:10.1016/0092-8674(92)90244-7 · Cited by 1,089
Apoptosis: The Biochemistry and Molecular Biology of Programmed Cell Death*
SCHWARTZMAN, R. A., & CIDLOWSKI, J. A. (1993) · Endocrine Reviews · doi:10.1210/edrv-14-2-133 · Cited by 1,040
Negative regulation of mitosis by wee1+, a gene encoding a protein kinase homolog
Russell, P., & Nurse, P. (1987) · Cell · doi:10.1016/0092-8674(87)90458-2 · Cited by 1,017
Gain of function mutations in p53
Dittmer, D., Pati, S., Zambetti, G., Chu, S., Teresky, A. K., Moore, M., Finlay, C., & Levine, A. J. (1993) · Nature Genetics · doi:10.1038/ng0593-42 · Cited by 894
p53-Dependent apoptosis suppresses tumor growth and progression in vivo
Symonds, H., Krall, L., Remington, L., Saenz-Robles, M., Lowe, S., Jacks, T., & Van Dyke, T. (1994) · Cell · doi:10.1016/0092-8674(94)90534-7 · Cited by 880
Barry, M. A., Behnke, C. A., & Eastman, A. (1990) · Biochemical Pharmacology · doi:10.1016/0006-2952(90)90733-2 · Cited by 867
Nelson, W. G., & Kastan, M. B. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.3.1815 · Cited by 857
THE IMPACT OF NATIONAL CANCER ACT
(1991) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/83.24.1797 · Cited by 796
Defects in a cell cycle checkpoint may be responsible for the genomic instability of cancer cells
Hartwell, L. (1992) · Cell · doi:10.1016/0092-8674(92)90586-2 · Cited by 770
Inhibition of CDK2 activity in vivo by an associated 20K regulatory subunit
Gu, Y., Turck, C. W., & Morgan, D. O. (1993) · Nature · doi:10.1038/366707a0 · Cited by 764
Induction of nuclear accumulation of the tumor-suppressor protein p53 by DNA-damaging agents.
Fritsche, M., Haessler, C., & Brandner, G. (1993) · PubMed · Cited by 747
Clinical toxicities encountered with paclitaxel (Taxol).
Rowinsky, E. K., Eisenhauer, E. A., Chaudhry, V., Sg, A., & Rc, D. (1993) · PubMed · Cited by 692
Epothilones, a new class of microtubule-stabilizing agents with a taxol-like mechanism of action.
Bollag, D. M., McQueney, P. A., Zhu, J., Hensens, O. D., Koupal, L. R., Liesch, J. M., Goetz, M., Lazarides, E., & Woods, C. M. (1995) · PubMed · Cited by 685
Self-citationClonal expansion of p53 mutant cells is associated with brain tumour progression
Sidransky, D., Mikkelsen, T., Schwechheimer, K., Rosenblum, M. L., Cavanee, W., & Vogelstein, B. (1992) · Nature · doi:10.1038/355846a0 · Cited by 670
A p53-Dependent Mouse Spindle Checkpoint
Cross, S. M., Sanchez, C. A., Morgan, C. A., Schimke, M. K., Ramel, S., Idzerda, R. L., Raskind, W. H., & Reid, B. J. (1995) · Science · doi:10.1126/science.7871434 · Cited by 660
p53 mutations increase resistance to ionizing radiation.
Lee, J. M., & Bernstein, A. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.12.5742 · Cited by 564
Cell death: a new classification separating apoptosis from necrosis
Wyllie, A. H. (1981) · Cell death in biology and pathology · doi:10.1007/978-94-011-6921-9_2 · Cited by 563
Premature p34 cdc2 Activation Required for Apoptosis
Shi, L., Nishioka, W. K., Th'ng, J., Bradbury, E. M., Litchfield, D. W., & Greenberg, A. H. (1994) · Science · doi:10.1126/science.8108732 · Cited by 557
Taxol: an antimitotic agent with a new mechanism of action
Manfredi, J. J., & Horwitz, S. B. (1984) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(84)90025-1 · Cited by 483
Heald, R., McLoughlin, M., & McKeon, F. (1993) · Cell · doi:10.1016/0092-8674(93)80048-j · Cited by 462
Regulation of microtubule dynamics by cdc2 protein kinase in cell-free extracts of Xenopus eggs
Verde, F., Labbé, J.-C., Dorée, M., & Karsenti, E. (1990) · Nature · doi:10.1038/343233a0 · Cited by 441
Cytotoxic studies of paclitaxel (Taxol®) in human tumour cell lines
Liebmann, J., Cook, J., Lipschultz, C., Teague, D., Fisher, J., & Mitchell, J. (1993) · British Journal of Cancer · doi:10.1038/bjc.1993.488 · Cited by 428
Dustin, P. (1984) · Springer eBooks · doi:10.1007/978-3-642-69652-7 · Cited by 417
Microtubule Organizing Centers
Brinkley, B. R. (1985) · Annual Review of Cell Biology · doi:10.1146/annurev.cb.01.110185.001045 · Cited by 414
A comparison of the biological activities of wild‐type and mutant p53
Zambetti, G. P., & Levine, A. J. (1993) · The FASEB Journal · doi:10.1096/fasebj.7.10.8344485 · Cited by 413
Taxol binds to cellular microtubules.
Manfredi, J. J., Parness, J., & Horwitz, S. B. (1982) · The Journal of cell biology · doi:10.1083/jcb.94.3.688 · Cited by 409
De Brabander, M., Geuens, G., Nuydens, R., Willebrords, R., & De Mey, J. (1981) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.78.9.5608 · Cited by 387
Bailly, E., Dorée, M., Nurse, P., & Bornens, M. (1989) · The EMBO Journal · doi:10.1002/j.1460-2075.1989.tb08581.x · Cited by 369
Schiff, P. B., & Horwitz, S. B. (1981) · Biochemistry · doi:10.1021/bi00514a041 · Cited by 368
Microtubule changes and cytotoxicity in leukemic cell lines treated with taxol.
Rowinsky, E. K., Donehower, R. C., Jones, R. J., & Tucker, R. W. (1988) · PubMed · Cited by 368
Activation of cyclin A-dependent protein kinases during apoptosis.
Meikrantz, W., Gisselbrecht, S., Tam, S. W., & Schlegel, R. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.9.3754 · Cited by 345
Control of programmed cell death in normal and leukemic cells: new implications for therapy
Sachs, L., & Lotem, J. (1993) · Blood · doi:10.1182/blood.v82.1.15.bloodjournal82115 · Cited by 284
Wiernik, P. H., Schwartz, E. L., Einzig, A., Strauman, J. J., Lipton, R. B., & Dutcher, J. P. (1987) · Journal of Clinical Oncology · doi:10.1200/jco.1987.5.8.1232 · Cited by 275
Bhalla, K. N., Ibrado, A. M., Tourkina, E., Tang, C., Mahoney, M. E., & Huang, Y. (1993) · PubMed · Cited by 273
Cell kill kinetics and cell cycle effects of taxol on human and hamster ovarian cell lines
Lopes, N. M., Adams, E. G., Pitts, T. W., & Bhuyan, B. K. (1993) · Cancer Chemotherapy and Pharmacology · doi:10.1007/bf00685842 · Cited by 271
Apoptosis Biochemical events and relevance to cancer chemotherapy
Sen, S., & D'Incalci, M. (1992) · FEBS Letters · doi:10.1016/0014-5793(92)80914-3 · Cited by 236
Mutations in p53 as potential molecular markers for human breast cancer.
Runnebaum, I. B., Nagarajan, M., Bowman, M., Soto, D., & Sukumar, S. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.23.10657 · Cited by 222
Cell line-specific differences in the control of cell cycle progression in the absence of mitosis.
Kung, A. L., Sherwood, S. W., & Schimke, R. T. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.24.9553 · Cited by 222
Participation of cyclin A in Myc-induced apoptosis.
Hoang, A. T., Cohen, K. J., Barrett, J. F., Bergstrom, D. A., & Dang, C. V. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.15.6875 · Cited by 206
Phase I and pharmacodynamic study of taxol in refractory acute leukemias.
Rowinsky, E. K., Burke, P. J., Karp, J. E., Tucker, R. W., Ettinger, D. S., & Donehower, R. C. (1989) · PubMed · Cited by 196
Berges, R. R., Furuya, Y., Remington, L., English, H. F., Jacks, T., & Isaacs, J. T. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.19.8910 · Cited by 192
Sheikh, M. S., Li, X. S., Chen, J. C., Shao, Z. M., Ordóñez, J. V., & Fontana, J. A. (1994) · PubMed · Cited by 191
A phase II study of taxol in patients with malignant melanoma
Einzig, A. I., Hochster, H., Wiernik, P. H., Trump, D. L., Dutcher, J. P., Garowski, E., Sasloff, J., & Smith, T. J. (1991) · Investigational New Drugs · doi:10.1007/bf00194546 · Cited by 180
The cellular oncogene p53 can be activated by mutagenesis
Jenkins, J. R., Rudge, K., Chumakov, P., & Currie, G. A. (1985) · Nature · doi:10.1038/317816a0 · Cited by 169
Da, F., & Rk, J. (1978) · PubMed · Cited by 162
The role of cell cycle progression in cisplatin-induced apoptosis in Chinese hamster ovary cells.
Demarcq, C., Bunch, R. T., Creswell, D., & Eastman, A. R. (1994) · PubMed · Cited by 146
Cytotoxic effects of cell cycle phase specific agents: result of cell cycle perturbation.
Kung, A. L., Zetterberg, A., Sherwood, S. W., & SCHIMKE, R. T. (1990) · PubMed · Cited by 142
Brabander, M. D., Geuens, G., Nuydens, R., Willebrords, R., Aerts, F., Mey, J. D., & McIntosh, J. R. (1986) · International review of cytology · doi:10.1016/s0074-7696(08)60250-8 · Cited by 139
Apoptosis and cancer chemotherapy
Hickman, J. A., Potten, C. S., Merritt, A. J., & Fisher, T. C. (1994) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.1994.0112 · Cited by 111
Liebmann, J., Cook, J. A., Lipschultz, C. A., Teague, D., Fisher, J. M., & Mitchell, J. B. (1994) · Cancer Chemotherapy and Pharmacology · doi:10.1007/bf00685909 · Cited by 102
O'Connor, P. M., Ferris, D. K., Ga, W., Pines, J., Hunter, T. R., Longo, D., & Kohn, K. W. (1992) · PubMed · Cited by 96
Death from inside out: an overview
Wyllie, A. H. (1994) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.1994.0099 · Cited by 69
Sherwood, S. W., Sheridan, J. P., & SCHIMKE, R. T. (1994) · Experimental Cell Research · doi:10.1006/excr.1994.1354 · Cited by 62
Devine, S. M., Geller, R. B., Holland, H. K., Wingard, J. R., & Saral, R. (1993) · PubMed · Cited by 59
Willingham, M. C., & Bhalla, K. N. (1994) · Journal of Histochemistry & Cytochemistry · doi:10.1177/42.4.7907352 · Cited by 57
Linkages between the effects of taxol, colchicine, and GTP on tubulin polymerization.
Howard, W. D., & Timasheff, S. N. (1988) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)57307-0 · Cited by 53
(1992) · PubMed
Cited by
Meijer, L., Borgne, A., Mulner, O., Chong, J. P. J., Blow, J. J., Inagaki, N., Inagaki, M., Delcros, J., & Moulinoux, J. (1997) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1997.t01-2-00527.x · Cited by 1,352
Gascoigne, K. E., & Taylor, S. S. (2008) · Cancer Cell · doi:10.1016/j.ccr.2008.07.002 · Cited by 832
Death through a tragedy: mitotic catastrophe
Vakifahmetoglu, H., Olsson, M., & Zhivotovsky, B. (2008) · Cell Death & Differentiation · doi:10.1038/cdd.2008.47 · Cited by 700
CYCLINS AND CELL CYCLE CHECKPOINTS
Johnson, D. G., & Walker, C. L. (1999) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.39.1.295 · Cited by 719
Stuck in Division or Passing through
Rieder, C. L., & Maiato, H. (2004) · Developmental Cell · doi:10.1016/j.devcel.2004.09.002 · Cited by 657
Metadata
- Authors
- Woods, C. M., Zhu, J., McQueney, P. A., Bollag, D., & Lazarides, E.
- Venue
- Molecular Medicine
- Published
- 1995-07
- Volume
- 1
- Issue
- 5
- Pages
- 506-526
- ISSN
- 1076-1551 (ISSN-L)
- 1528-3658
- OpenAlex
- W180777263
- Cited by
- 282
- References
- 76
- FWCI
- 3.02
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.